BioAv Cancer Research Results

BioAv, bioavailability: Click to Expand ⟱
Source:
Type: measurement
Bioavailability (usually in %) absorbed by the body.


NA, Not Available: Click to Expand ⟱
none (reserved)

Scientific Papers found: Click to Expand⟱
1516- EGCG,    Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential
- Review, NA, NA
*Dose∅, Half-Life∅, BioAv∅, BBB↑, toxicity∅, eff↓, Apoptosis↑, Casp3↑, Cyt‑c↑, cl‑PARP↑, DNMTs↓, Telomerase↓, angioG↓, Hif1a↓, NF-kB↓, MMPs↓, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓, P53↑, PTEN↑, IGF-1↓, H3↓, HDAC1↓, *LDH↓, *ROS↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death

Apoptosis↑, 1,   Bak↑, 1,   BAX↑, 1,   Bcl-2↓, 1,   Bcl-xL↓, 1,   Casp3↑, 1,   Cyt‑c↑, 1,   Telomerase↓, 1,  

Transcription & Epigenetics

H3↓, 1,  

DNA Damage & Repair

DNMTs↓, 1,   P53↑, 1,   cl‑PARP↑, 1,  

Proliferation, Differentiation & Cell State

HDAC1↓, 1,   IGF-1↓, 1,   PTEN↑, 1,  

Migration

MMPs↓, 1,  

Angiogenesis & Vasculature

angioG↓, 1,   Hif1a↓, 1,  

Barriers & Transport

BBB↑, 1,  

Immune & Inflammatory Signaling

NF-kB↓, 1,  

Drug Metabolism & Resistance

BioAv∅, 1,   eff↓, 1,   Half-Life∅, 1,  

Functional Outcomes

toxicity∅, 1,  
Total Targets: 24

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

ROS↓, 1,  

Core Metabolism/Glycolysis

LDH↓, 1,  

Drug Metabolism & Resistance

Dose∅, 1,  

Clinical Biomarkers

LDH↓, 1,  
Total Targets: 4

Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:0  Cells:%  prod#:%  Target#:792  State#:%  Dir#:6
wNotes=0 sortOrder:rid,rpid

 

Home Page